Embecta Corp. reports Q2 fiscal 2026 financial results and announces a $0.01 quarterly dividend.

Embecta Corp., a global medical supplies company with a 100-year legacy in insulin delivery, reported its second quarter fiscal 2026 financial results on May 5, 2026. The company also declared a quarterly cash dividend of $0.01 per share. Embecta continues to focus on expanding its medical supplies business and improving lives through innovative solutions. Investors can access the detailed earnings release and listen to the company's conference call for more insights.